TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss
TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss
Read moreMon, 18th Nov 2019 16:00
TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss
Read more(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Wednesday that the new-generation 'Genedrive System' platform, which was developed to support the commercial launch of the 'Genedrive MT-RNR1' ID kit, had now received CE-IVD marking in anticipation of launch in the UK and the European Union.
Read moreUK shareholder meetings calendar - next 7 days
Read moreTRADING UPDATES: Argo gets GBP18 million loan; Genedrive fundraises
Read moreTRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live
Read more(Sharecast News) - Molecular diagnostics company Genedrive said on Tuesday that it will soon launch its MT-RNR1 assay, used for the detection of antibiotic-induced hearing loss in newborns.
Read moreTRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free
Read more(Sharecast News) - Molecular diagnostics company Genedrive updated the market on the development of its 'COV19-ID Kit', a rapid point-of-care molecular test for SARS-CoV-2 detection designed for its 'Genedrive instrument', on Thursday.
Read moreIN BRIEF: Genedrive receives Indian import license for Covid test kit
Read more(Sharecast News) - Molecular diagnostics company Genedrive announced on Friday that the 'Genedrive 96' SARS-CoV-2 kit had been formally approved by the Indian Council of Medical Research (ICMR).
Read moreGenedrive shares surge after Covid test approved by Indian regulator
Read moreAIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"
Read moreGenedrive says study shows kit is effective at diagnosing Hepatitis C
Read moreUPDATE: Yourgene wins further national framework contract award
Read moreIN BRIEF: Genedrive included in Public Health England framework
Read more